MétaCan
Menu
Back to cohort
Record W2948407021 · doi:10.1111/jch.13563

Prescription of renin‐angiotensin‐aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care

2019· article· en· W2948407021 on OpenAlexafffund
Roberto Pecoits‐Filho, Danilo Fliser, Charlotte Tu, Jarcy Zee, Brian Bieber, Michelle Wong, Friedrich K. Port, Christian Combe, Helmut Reichel, Ichiei Narita, Bénédicte Stengel, Bruce Robinson, Ziad A. Massy

Bibliographic record

VenueJournal of Clinical Hypertension · 2019
Typearticle
Languageen
FieldMedicine
TopicPotassium and Related Disorders
Canadian institutionsUniversity of British Columbia
FundersJanssen PharmaceuticalsMedical Research CouncilEuropean Renal Association-European Dialysis and Transplant AssociationChulalongkorn UniversityInstitut National de la Santé et de la Recherche MédicaleNational Institute for Health and Care ResearchNational Research Council of ThailandAgence Nationale de la RechercheKing Chulalongkorn Memorial HospitalMSD FranceSanofiNational Health and Medical Research CouncilFresenius Medical Care North AmericaAstraZenecaEli Lilly and CompanyGlaxoSmithKlineOtsuka PharmaceuticalJapan Agency for Medical Research and DevelopmentCancer Care OntarioThailand Research FundAmgen
KeywordsMedicineMedical prescriptionKidney diseaseHeart failureInternal medicineDiabetes mellitusHyperkalemiaNephrologyCardiologyEndocrinologyPharmacology

Abstract

fetched live from OpenAlex

Renin-angiotensin-aldosterone system inhibitors (RAASi) are recommended for chronic kidney disease (CKD) patients. In this study, we describe RAASi prescription patterns in the Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps) in Brazil, Germany, France, and the United States (US). 5870 patients (mean age 66-72 years; congestive heart failure [CHF] in 11%-19%; diabetes in 43%-54%; serum potassium ≥5 in 20%-35%) were included. RAASi prescription was more common in Germany (80%) and France (77%) than Brazil (66%) and the United States (52%), where the prevalence of prescription decreases particularly in patients with CKD stage 5. In the multivariable regression model, RAASi prescription was least common in the United States and more common in patients who were younger, had diabetes, hypertension, or less advanced CKD. In conclusion, RAASi prescription patterns vary by country, and by demographic and clinical characteristics. RAASi appear to be underused, even among patients with strong class-specific recommendations. Although the reasons for this variation could not be fully identified in this cross-sectional observation, our data indicate that the risk of hyperkalemia may contribute to the underuse of this class of agents in moderate to advanced CKD.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.019
Threshold uncertainty score0.038

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.019
GPT teacher head0.286
Teacher spread0.268 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations66
Published2019
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical HypertensionSame topicPotassium and Related DisordersFrench-language works237,207